These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 18382182

  • 1. Topiramate in essential tremor: findings from double-blind, placebo-controlled, crossover trials.
    Connor GS, Edwards K, Tarsy D.
    Clin Neuropharmacol; 2008; 31(2):97-103. PubMed ID: 18382182
    [Abstract] [Full Text] [Related]

  • 2. Topiramate in essential tremor: a double-blind, placebo-controlled trial.
    Ondo WG, Jankovic J, Connor GS, Pahwa R, Elble R, Stacy MA, Koller WC, Schwarzman L, Wu SC, Hulihan JF, Topiramate Essential Tremor Study Investigators.
    Neurology; 2006 Mar 14; 66(5):672-7. PubMed ID: 16436648
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J, Topiramate Chronic Migraine Study Group.
    Headache; 2007 Feb 14; 47(2):170-80. PubMed ID: 17300356
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerability of pregabalin in essential tremor: a randomized, double-blind, placebo-controlled, crossover trial.
    Ferrara JM, Kenney C, Davidson AL, Shinawi L, Kissel AM, Jankovic J.
    J Neurol Sci; 2009 Oct 15; 285(1-2):195-7. PubMed ID: 19631949
    [Abstract] [Full Text] [Related]

  • 5. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW, Freitag F, Banks J, Saper J, Xiang J, Rupnow M, Biondi D, Greenberg SJ, Hulihan J, CAPSS-277 Investigator Group.
    Clin Ther; 2009 Mar 15; 31(3):542-59. PubMed ID: 19393844
    [Abstract] [Full Text] [Related]

  • 6. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ, TOPMAT-MIG-201(TOP-CHROME) Study Group.
    Cephalalgia; 2007 Jul 15; 27(7):814-23. PubMed ID: 17441971
    [Abstract] [Full Text] [Related]

  • 7. Levetiracetam is not effective for essential tremor.
    Elble RJ, Lyons KE, Pahwa R.
    Clin Neuropharmacol; 2007 Jul 15; 30(6):350-6. PubMed ID: 18090460
    [Abstract] [Full Text] [Related]

  • 8. Carisbamate in essential tremor: brief report of a proof of concept study.
    Elble RJ, Biondi DM, Ascher S, Wiegand F, Hulihan J.
    Mov Disord; 2010 Apr 15; 25(5):634-8. PubMed ID: 20201005
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study.
    Silberstein SD, Hulihan J, Karim MR, Wu SC, Jordan D, Karvois D, Kamin M.
    Clin Ther; 2006 Jul 15; 28(7):1002-11. PubMed ID: 16990078
    [Abstract] [Full Text] [Related]

  • 10. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
    Rapoport A, Mauskop A, Diener HC, Schwalen S, Pfeil J.
    Headache; 2006 Jul 15; 46(7):1151-60. PubMed ID: 16866719
    [Abstract] [Full Text] [Related]

  • 11. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
    Silberstein S, Lipton R, Dodick D, Freitag F, Mathew N, Brandes J, Bigal M, Ascher S, Morein J, Wright P, Greenberg S, Hulihan J.
    Headache; 2009 Sep 15; 49(8):1153-62. PubMed ID: 19719543
    [Abstract] [Full Text] [Related]

  • 12. A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor.
    Zesiewicz TA, Ward CL, Hauser RA, Sanchez-Ramos J, Staffetti JF, Sullivan KL.
    Mov Disord; 2007 Jan 15; 22(2):279-82. PubMed ID: 17149715
    [Abstract] [Full Text] [Related]

  • 13. A double-blind placebo-controlled trial of topiramate treatment for essential tremor.
    Connor GS.
    Neurology; 2002 Jul 09; 59(1):132-4. PubMed ID: 12105323
    [Abstract] [Full Text] [Related]

  • 14. Safety and effectiveness of topiramate for the management of painful diabetic peripheral neuropathy in an open-label extension study.
    Donofrio PD, Raskin P, Rosenthal NR, Hewitt DJ, Jordan DM, Xiang J, Vinik AI, CAPSS-141 Study Group.
    Clin Ther; 2005 Sep 09; 27(9):1420-31. PubMed ID: 16291415
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and Safety of Topiramate for Essential Tremor: A Meta-Analysis of Randomized Controlled Trials.
    Chang KH, Wang SH, Chi CC.
    Medicine (Baltimore); 2015 Oct 09; 94(43):e1809. PubMed ID: 26512577
    [Abstract] [Full Text] [Related]

  • 16. A placebo-controlled, random-assignment, parallel-group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type.
    Roy Chengappa K, Kupfer DJ, Parepally H, John V, Basu R, Buttenfield J, Schlicht P, Houck P, Brar JS, Gershon S.
    Bipolar Disord; 2007 Sep 09; 9(6):609-17. PubMed ID: 17845276
    [Abstract] [Full Text] [Related]

  • 17. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
    Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J, Topiramate Pediatric Migraine Study Investigators.
    Headache; 2005 Sep 09; 45(10):1304-12. PubMed ID: 16324162
    [Abstract] [Full Text] [Related]

  • 18. Zonisamide for essential tremor: an evaluator-blinded study.
    Handforth A, Martin FC, Kang GA, Vanek Z.
    Mov Disord; 2009 Feb 15; 24(3):437-40. PubMed ID: 19117357
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb 15; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 20. The impact of topiramate on health-related quality of life indicators in chronic migraine.
    Dodick DW, Silberstein S, Saper J, Freitag FG, Cady RK, Rapoport AM, Mathew NT, Hulihan J, Crivera C, Rupnow MF, Mao L, Finlayson G, Greenberg SJ.
    Headache; 2007 Feb 15; 47(10):1398-408. PubMed ID: 18052949
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.